Abstract: Stem cell (SC) and cancer stem cell (CSC) regulation is congregated around the dynamic role played by their niche that defines a domain-specific identity and functions. The major macromolecular components of any physiological niche are collectively referred to as Extra Cellular Matrix (ECM). Consequently, niche-determined governance of SC-CSC fate(s) is significantly wired by the ECM and its chemical undercurrents, which involve specific signaling cascades driving asymmetrical division and self-renewal, besides maintaining tissue and organ homeostasis. Cell transformation is often associated with variations in ECM composition and dynamics; although the distinction of whether these are a cause or an effect of the process is not clearly established. CSCs regulate altered ECM subtleties; these in turn support disease progression by providing the necessary cues to maintain CSC quiescence and regeneration yet drive cancer metastases. Further, the specific composition of altered ECM plays a critical role in metastatic dissemination and homing to specific secondary sites for tumor regeneration. The present review presents our understanding of modulation of SC and CSC interactions in their respective niche by ECM components, and a complementary focus of intonation of ECM biochemistry by these cells in developing an aberrant phenotype.
INTRODUCTION
Stem cells (SCs) are central to the maintenance of tissue homeostasis through their unique self-renewal and regenerative capabilities, which result in multi lineage differentiation towards fulfilling the local requirements of an organ [1] [2] [3] . Such varying cell fate decisions are largely brought about by subtle changes in the microenvironment that activate appropriate signaling pathways. The complex set of input signals includes, but is not limited to, dissolved oxygen, soluble factors, hormones and cytokines (that regulate through autocrine and paracrine mechanisms), extra cellular matrix (ECM) components, direct cell-cell interaction and the spatial organization of cells within tissues [4] . Conventionally, stem cell fate governance by transcription factors, growth-modulators and hormones is recognized to be mediated by cross-talk between Wnt, Notch, sonic hedgehog (SHH); phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K), mitogen activated kinase-like protein (MAPK), transforming growth factor-beta (TGFb) signaling networks [5] [6] [7] [8] [9] . Signaling cascades culminate in asymmetrical division and/or differentiation that can be conveniently tracked by profiling dynamically changing cell membrane surface markers over the regenerative hierarchy [10] .
Transformation of stem cells or acquisition by differentiated cells of 'stemness' features enabling them to undergo self-renewal, generate phenotypic heterogeneity in their progeny, resistance to external regulatory stimuli among others leads to generation and evolution of cancer stem cells (CSCs) [11] . These cells constitute a very small population of a tumor and exhibit multiple types of genetic alterations than their cell-of-origin. Chromosomal rearrangements, nucleotide mutations like point and indel, epigenetic changes have been traced in CSCs [11] . Just like stem cells are regulated and influenced by microenvironment including extracellular matrix (ECM), cancer stem cells are increasingly being realised to be regulated by ECM.
Thereby, by virtue of being the major non-cellular component of the niche, ECM is increasingly receiving attention with respect to the contribution of various molecules, their synthesis and regulation in maintaining normal tissue homeostasis [12] [13] [14] . Complementing and participating as essential components of signaling pathways, ECM assumes a role as being an important determinant of cellular fate and behavior. Initial events influenced by ECM in the life-span of an organism are during development of a zygote into a multicellular structure, and include imparting the first cues of instructing cellular polarity [15] [16] [17] .
Such models further provide pertinent information associating altered ECM compositions with tissue dysregulation that could lead to disease. One such effect is in cellular transformation and generation of tumor-initiating cells (TICs) that regenerate an abnormal organ and maintain it along principles convincingly similar to that of normal SC regeneration; thereby such cells are also referred to as Cancer Stem Cells (CSCs). Both SCs and CSCs have immense cross-talk with ECM. Further, parallels drawn between tumor emergence and embryo development indicate that altered cellular polarity is an early change brought about by altered ECM composition and is one of the features involved in transformation, tumor progression and metastases. Moreover, CSCs regulate the tissue microenvironment by establishing a molecular circuitry that defines further tumor growth, extracellular remodelling, angiogenesis and metastasis associated kinetics. Unfortunately, most studies focus on similarities between wound healing and epithelial-to-mesenchymal transitions (EMT) while contribution of ECM constituents has been side lined [18, 19] . Drastic changes in ECM composition of tissues have been attributed to disease state like cardiovascular diseases [20] , cancer [21] , lung pathogenesis [22] , and atherosclerosis [23] among others.
The present review focuses on the governance of SCand CSC-niche interactions involving the ECM and analyzes how its various elements condition quiescence, differentiation, invasion-/migration and cell survival.
Transformation and emergence of CSCs
Like SCs in their natural niche, CSCs constitute a small fraction of the total tumor, exhibit a hierarchical regenerative system and are also responsible for initiation and perpetuation of the tumor microenvironment [24] [25] [26] [27] . Again, similar to that of SCs, CSC functioning is modulated by intrinsic and extrinsic signals of the tumor microenvironment [28] . These signals cooperatively mediate bi-directional paracrine signaling between the microenvironment and tumor cells that contribute by secreting factors that regulate other cells within the niche [29] [30] [31] [32] . Thus factors including Wnt, Notch and Hedgehog ligands, insulin-like growth factor (IGF), platelet-derived growth factor (PDGF) and Matrix metalloproteinases (MMPs) are produced and are involved in the PI3K, NF-kB, Wnt, Hedgehog, Notch and Jak/STAT pathways to regulate tumor growth, progression and metastasis [31, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . These pathways establish crucial cross-talk with various ECM molecules. Epigenetic changes are the early events in the carcinogenesis and tumor profiling indicates similarities with SC [43] . In an emerging CSC niche, activation and divergence of quiescent fibroblasts to express an altered phenotype as that of CAFs is mediated through DNA methylation changes as reported in breast and colorectal cancer [44, 45] . Such activated CAFs secrete TGFb and chemokine (C-X-C motif) ligand 12 (CXCL12) which subsequently promote tumor cell proliferation and migration [46] [47] [48] .
Apart from roles in niche development and cellular heterogeneity, CSCs ensure survival under the onslaught of genotoxic stress and therapeutic toxicity [49, 50] . This resistance is due to exodus of chemotherapeutic agents by drug efflux pumps, sequestering the drugs and preventing conventional drugs from reaching transformed cells [51] , and enhanced DNA damage repair machinery [52, 53] . Such small events cumulate into sustenance of transformed cells. Cell surface expression of hyaluronic acid is involved in the maintenance of Lineage negative (Lin À ) stem cells; its extracellular presence can substitute hypoxic conditions and also provides protection against reactive oxygen species (ROS) preventing oxidative damage to DNA [54] . These factual events although observed in untransformed cells can be extrapolated towards the emergence of transformed cells and augment CSC and niche emergence. Figure 2 gives an overview on role of ECM in emergence, metastases and resistance provided to CSC niche. Expression of certain cell surface specific markers frequently shared by CSCs of different types include CD20, CD24, CD44 (breast, prostate, colon, pancreatic, melanoma, hepatic carcinoma), CD34, CD44, CD90, CD117, CD133, CD166, EpCAM, ESA, b1 integrin chain, ABCG2 [55, 56] .
Extracellular matrix
Metazoan cells are surrounded by a macromolecular heterogeneous system that is collectively referred to as ECM [57] . Secreted by stromal and endothelial cells [58] , it mostly consists of proteins, glycoproteins, proteoglycans, glycosaminoglycans and polysaccharides gelled in water [59, 60] . The ever-changing constituents of ECM in the microenvironment govern cellular and organ dynamics by imparting varied degree of physical, biochemical and bio-mechanical properties to tissues, thereby regulating cellular behavior and developmental processes [61] [62] [63] [64] . These principles are especially relevant to the SC and CSC niche where diverse cell types are known to interact [63] .
Composition
Structurally, ECM is divided into two components including the Basement Membrane (BM) and Interstitial Matrix (IM) [65] . BM is a coalescence of more than 50 distinct macromolecules, predominantly laminins and type-IV collagen [66] [67] [68] [69] [70] . Both these molecules are capable of self-assembling and form the basic supramolecular network surrounding the cell surfaces of epithelial, endothelial and muscle cells, adipocytes and nerves. Linker proteins including nidogens, proteoglycans like perlecan, agrin, collagen XV and collagen XVIII are other major constituents of BM [71] . BM is produced by endothelial, epithelial and stromal cells with the primary function of anchorage to the surrounding cell surface. It is also responsible for acting as a mechanical barrier regulating and filtering the macromolecules and penetration of cells [72] . IM comprises of proteoglycans, non-proteoglycan polysaccharides like hyaluronan that is mostly synthesized by stromal cells, fibrous proteins like collagen and elastin and glycoproteins [58, 71] . The composition of BM and IM changes spatially and temporally depending on the tissue [65, 73] . While laminins and linker proteins are more frequently associated with BM, they are also present in IM, albeit to a lesser extent. Figure 1 illustrates the major structural components of ECM and presents a classification based on composition, location and functions. Based on their functional aspects, some ECM components are often also categorised as matricellular proteins (Box 1).
Other components and their amount depend on the tissue type and physiological state. The most common ones include the growth hormones-fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor-beta (TGFb), platelet-derived growth factor (PDGF), insulin-like growth factor (IGF) [74] , etc. Almost all, either by themselves or in combination lead to proliferation [75] . Other examples include -promotion of self-renewal in pluripotent stem cells by Fibroblast growth factor-2 [9] ; TGFb guidance of stem cell fate during development and regulation of a plethora of homeostatic genes for maintenance in adults [76] ; chemo-and radio-therapy resistance by overexpression of epidermal growth factor receptor (EGFR) that is an important consideration in improving prognosis [77] . Numerous stromal modulators including tumor growth factor-beta (TGFb), tumor necrosis factor a (TNFa), colony stimulating factor-1, interleukins, epidermal growth factor receptor (EGFR) ligands are synthesized and secreted as a part of normal tissue functioning in coordination with expression and regulation with ECM components like heparin and hyaluronan that leads to cross-talk as an integral part of autocrine-paracrine signaling [78] . In fact, the significance of such associations is emphasized by their effects in regulation of ovulation [79] ; neural stem cell regulation in sub ependymal zone [80] ; post-injury skeletal muscle healing [81] and wound repair [82] that also involves metalloproteinases (MMPs) and cathepsins to mediate the degradation of BM and deposition of ECM proteins like collagen I and IV, fibronectin, laminin and matricellular proteins [83] (Box 2).
CROSS-TALK BETWEEN ECM AND STEM CELLS (SC)
The stem cell niche regulates stem cell behaviour by providing a defined cellular and molecular microenvironment that permits stem cell self-renewal, proliferation and differentiation [84, 85] . Major functional niche components include supporting niche cells, growth-modulating soluble factors stored within the niches, and the extracellular matrix [86] [87] [88] . The ECM provides the necessary cues for asymmetrical divisions that contribute to stem cell fate. The self-renewing and differentiated cell states are determined by the cells exposed to the niche, whereby one daughter cell exposed to the SC niche remains as an undifferentiated SC, while the other responds to growth signals from ECM components and develops into a transiently amplifying progenitor that establishes the regenerative stem cell hierarchy [89] . Thus, the extent of ECM on SC fate influences growth and development of the tissue.
Physical influences of ECM on SC
The composition of ECM determines its physical nature that in turn influences SC fate. Adherence to substrate allows cells to exert contractile forces [90] . The plasticity of the ECM influences the cellular elasticity as in migration [91, 92] , apoptosis [93] , and proliferation [94] . It has been identified that differentiation lineage of mesenchymal stem cells (MSCs) is defined by the plasticity of the substrate; hard substrates like that of bone lead to differentiation primarily along the osteogenic lineage, while substrates mimicking relatively soft tissues like brain lead to neurogenic differentiation [95, 96] . Uniaxial strained adipose-derived SCs that are deprived of ECM show decreased expression of myogenic markers [97] . ECM thus can mediate biological effects through subtle changes in its composition that alters the mechanical forces of the microenvironment. Such mechanical signal transduction also involves RhoA-mediated actin modulation and Transient receptor potential (TRP) channel-mediated signaling [98] [99] [100] [101] [102] . The differences in SC fate under the influence of ECM with different mechanism-transduction properties thus provide an understanding of mechanical effects of the environment on biological processes.
Chemical and molecular ECM dynamics governing SC fate
Interestingly, it remains a fact that multiple tissues of the body have similar elasticity and hence it must be noted that the physical nature of ECM necessarily plays in concert with its chemical composition [103] . Integration of the physical trigger with chemical and molecular elements of ECM specifies the physiological input shaping cellular activities. Niche signals often act in short range, and may be required continuously for SC maintenance. The signals that culminate into activation of SC leading to SC Box 1. Matricellular proteins Matricellular proteins are spatially and temporally regulated components not involved in the structural maintenance of the ECM. These have context-specific and short-range functions in cellular physiology. These proteins include thrombospondins, tenascins, SPARC family, osteopontin, periostin and fibulins. Since the inception of term (224) , this family is increasing by numbers (225).
Box 2. ECM re-modellers
ECM remodelling is achieved by proteases like MMP-2, MMP-9, urokinase and tissue type plasminogen activator (TPA) (226) . MMPs secreted as latent zymogens are activated upon conformational changes leading to unmasking of catalytic domain (227, 228) . MMPs are a class of 25 enzymes with major studies focused on MMP-2 (Gelatinase A) and MMP-9 (Gelatinase B) as these are widely expressed during the tissue remodelling (229, 230) . The function of MMPs is not limited to proteolytic activity, MMPs also aid in self-renewal of ESCs by activation of Stat3 (231) . expansion and tissue growth include a cocktail of ECM small molecules and soluble factors buffered within the matrix.
Soluble factors
The SC niche commonly responds readily to hormonal stimuli buffered within ECM. Mammary stem cells (MaSCs) are stimulated in response to endocrine signals emitting from the hypothalamus-pituitary-ovary axis during puberty [104] . Addition of basic fibroblast growth factor (bFGF) can maintain undifferentiated human embryonic stem cells (hESCs) when used at high concentrations [105] . Erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) also maintains hESCs in vitro in absence of bFGF [106] . Heregulin-1B, Activin A, insulin-like growth factor-1 (IGF-1), and bFGF activate v-erb-b2 avian erthroblastic leukemia viral oncogene homolog 2 (ERBB2) receptor and insulin-like growth factor-1 receptor (IGF1R) signaling for hESC self-renewal [107] . Inhibition of glycogen synthase kinase 3 (GSK-3) signaling by 2 mM 6-bromoindirubin-3 0 -oxime (BIO) maintains hESCs pluripotency [108] .
Small molecules of ECM components
ECM constitution within the niche also plays critical roles in pathways leading in maintenance of pluripotency or differentiation. ESCs differentiated into different cell types when subjected to various small molecules -insulin and triiodothyronine (T3) induced adipogenesis, TGFb3 to induced chondrogenesis while bone morphogenetic protein-4 (BMP-4) induced osteogenesis [109] . Abstinence of TGFb leads to hematopoietic differentiation [110] . Interaction with laminin-511 in substratum or niche maintains human pluripotent stem cells (hPSC) in undifferentiated state under in vitro conditions [111] . The heparin-binding peptide derived from vitronectin supports human pluripotent stem cells (hPSC) self-renewal and adhesion to substrates [112] . Collagen leads to increased proliferation in adipose-derived SC while cross linked hyaluronic acid (HA) causes differentiation [113] .
INTERACTIONS OF ECM AND CSC:
A DIFFERENT BALL GAME? 3.1 Synthesis and regulation Besides neoplastic cells, the tumor microenvironment includes non-transfomed cells of the stroma, endothelial cells, fibroblasts, immune cells, etc. [114] [115] [116] . Cancer Associated Fibroblasts (CAFs) are sourced locally and reprogrammed to support disease progression [117] [118] [119] . The transformation of local fibroblasts could be mediated through DNA methylation [44, 45] . CAFs contribute to tumor growth and spread by release of epidermal growth factor (EGF), TFG-b, hepatocyte growth factor (HGF) [118] , and further develop and condition the tumor niche through synthesis of cellular components of the vascular network, soluble factors. Thereby, normal and tumor stroma display distinct differences [120, 121] ; similarly, leukemic BM differs from normal physiologic BM in its composition of which ECM constituents are significantly altered [122] [123] [124] [125] . Table 1 shows the specific interactions of various CSCs with ECM in their niche.
Role of ECM in cancer niche development and metastases
The current school of thought suggests that transformation of a cell is the first step towards establishment of a tumor. However recent elegant experimentation emphasizes equal contribution of tumor stroma and altered microenvironment in the process of tumor initiation. The tumor niche has active participation of non-tumor origin cellsmostly the endothelial cells and the stromal cells which help in the development of pro-angiogenic microenvironment required for sustenance of tumor [126] . The perivascular niche in glioblastoma multiform involves vascular endothelial cells and neural cancer stem cells to come together and stay in close proximity to each other [127] . This is promoted by nitric oxide produced by endothelial cells activating Notch pathway in glioma CSCs which subsequently secrete vascular endothelial growth factor A (VEGF) promoting angiogenesis [128, 129] . Colon CSC niche studies have developed on the lessons of heritable juvenile polyposis syndrome which identified importance of tumor stroma for the colorectal cancer development [127] . With tumor-associated myofibroblasts (TAF) being significant cellular component of colon cancer stroma, they secrete large amounts of type I collagen which promotes stem cell-like phenotype in colorectal carcinoma cell lines [130] . Within the osteoblastic niche, the tumor suppressor retinoblastoma (RB) gene extrinsically regulates HSCs by maintaining the competence of the adult bone marrow to support their growth and normal homeostatic hematopoiesis. Loss of RB expression in the niche and myeloid cells leads to myeloid development that ultimately culminates in myeloproliferative disease [131] (MPS). This suggests sequential changes leading to alteration of niche components that finally culminates into epithelial transformation.
Cancer niche development
Dedifferentiation has been identified in association with transformation, and is supported by normal niches [132, 133] . Such transformed cells with acquired 'stem cell-like properties' compete with normal stem cells in the niche and manifest themselves as dominant clone(s) within the developing tumor [134, 135] . This changing cellular composition further influences the niche to promote proliferation and maintenance of transformed clones [136, 137] . Active cross-talks mediated by autocrine-paracrine signals mark enhanced tumor growth, while drug treatment can lead to apoptosis of transformed cells. However, specific ECM components protect cells from drug action through cell adhesion-mediated drug resistance (CAM-DR). Thus, resistance to drugs like cisplatin, etoposide, melphalan, mitoxantrone and cyclophosphamide [138] [139] [140] [141] has been attributed to their capturing and subsequent sequestering by ECM proteins like fibronectin, laminin, and collagen. Furthermore, this effect was shown to be dependent on the interaction of the ECM proteins with the cell membrane receptor b1-integrin [138, 139, 141] .
Role of ECM in metastases
During tumor progression, ECM undergoes significant remodelling mediated largely by proteinases including MMPs that are produced by the tumor stroma [142] (Box 2). This phenomenon is often accompanied by tumor cells chances that break away from the primary site and become invasive. Detachment from the primary tumor involves down-regulation of cell junction components including Ecadherin leading to progressive loss of epithelial markers, cell-cell contact and simultaneous expression of mesenchymal proteins (Vimentin, N-cadherin) through a process described as epithelial to mesenchymal transition (EMT) [143, 144] . EMT is also facilitated by growth hormones including TGFb, epidermal growth factor (EGF), fibroblast growth factor (FGF) and ECM macromolecules including osteopontin (OPN), periostin (POSTN), secreted protein acidic and rich in cysteine (SPARC) and tenascin C (TNC) [117, 145] (Figure 2) . TGFb produced by stromal cells induces cellular mobility by releasing MMP-9, Hyaluronan-mediated motility receptor (HMMR), periostin (POSTN) and versican (VCAN); In situ RHAMM protein expression in AML suggests poor overall survival. 212 Liver Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
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CD44s regulates the TGF-b-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. 
Esophageal cancer
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma formation; yet high expression in tumors is associated with poor patient outcome.
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Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth 222 Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential
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Stem cell and cancer stem cell games on the ECM fieldVCAN further activates NF-kB signaling and up-regulates expression of CD44, MMP-9 and HMMR [146] . It is reported that the CSC pool is expanded by presence of TGFb, thus increasing the chances for metastatic spread [147] [148] [149] . Specific transcription factors such as Slug and Snail mediate EMT; these are often at the tumor-stroma interface and/or at the migrating tumor edge [150, 151] . Recently, the ECM molecule SPARC has been demonstrated to regulate Slug by PI3K/Akt pathway [152] . Figure 3 illustrates the role of various ECM components in driving cellular migration. Apart from the constituents playing their role via signaling receptors, a mechanical stress generated by the tightening of collagen fibres mediated by lysyl oxidase (LOX) enzymes also has cell transitional abilities [58] (Box 3). The pressure created by the collagen fibres creates an internal pressure within the niche, which coerces cells to move out of the niche. These forces, accompanied by proteinase action pave the way for cellular migration. Migrating cells transcend into the circulation and survivors develop a niche for secondary site through secretion of soluble factors, growth factors and ECM proteins by establishing cross-talk with the endothelial cells [153] . Stable levels of osteopontin and elevated levels of tenascin C and periostin have thus been shown to promote metastatic colonization [86, 154, 155] . Tenascin also maintains the breast CSC populations [156] . Interestingly, periostin secretions were demonstrated to be from the stromal fibroblasts in lungs of metastasis-positive animals, and not by tumor cells [86] .
Regulation of quiescence by ECM
Quiescence or dormancy is a predominant resting, cell cycle stage (G 0 ) essential for the long-term sustenance of SC-and CSC-mediated regeneration. Due to its reversible nature, the process facilitates maintenance of a reserve population that can replenish the regenerative hierarchies in normal tissues on a long-term basis, for the life of an individual [157] . The same also permits tumor cells to evade and develop resistance to regular chemotherapies which target rapidly dividing cells. This is maintained by intrinsic p53, reactive oxygen species (ROS), Ataxia telangiectasia mutated (ATM), forkhead box type O (FoxO), hypoxia inducible factor 1a (HIF1a), Nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 (NFATc1) and extrinsic cell factors (Tie2/Ang-1), TGFb, bone morphogenetic protein (BMP), thrombopoietin (TPO), N-cadherin, integrins, osteopontin (OPN), Wnt/ b-catenin pathway). Tie2/Angiopoietin-1 (Ang-1) signaling activates b1-integrin and N-cadherin and promotes HSC interactions with ECM components [158, 159] . Quiescent fibroblasts present in the niche get activated to enter cell cycle upon injury generating large amount collagen-rich ECM [160] . Recently, the cross-regulation of quiescence and proliferation by thrombospondin-1 (TSP-1) and periostin (POSTN) is reported [161] ; presence of high TSP-1 sustains quiescence of breast cancer disseminated tumor cells (DTC), while reduction in TSP-1
Box 3. Mechanical forces regulate Transcription Factor (TF) to govern cell fate
From the development of blastocyst to maintenance of adult organs, the mechanical forces provide the necessary cues which culminate in regulation of TF. During development, the blastocoel expands to push the inner cell mass (ICM) against zona pellucida (ZP) which induces activation of TF-Oct4, Sox2, Nanog. Excess of mechanical force leads pro-inflammatory proteins like tumor necrosis factor a (TNFa), thus altering tissue structure. and TGFb triggered expression of POSTN and re-entry into cell cycling. Although understanding the functionality of ECM components in quiescence in CSC is in nascent stages, it is interesting that the pathways involved in the stem cell quiescence regulation are similarly expressed in CSCs [162, 163] .
3.4 Functionality of CD44, an important CSC marker CD44 is a transmembrane glycoprotein that functions as a specific receptor for hyaluronic acid (HA), and is associated with proteins involved in detecting niche dynamics [164] . This molecule is implicated in diverse processes including promotion and regulation of cell adhesion, proliferation, growth, survival, motility, migration, angiogenesis and differentiation [164, 165] . Besides mediating signaling downstream of HA (Figure 3 ) it interacts with other ECM components including osteopontin, collagen, laminin, integrins, mucosal vascular addressin, serglycin/ gp600 and the MHC class II invariant chain [166] . Apart from such signaling, it also presents cytokines and chemokines on the cell membrane.
Several CD44 isoforms are known with a range in molecular weight from 80 to > 200 kDa [167] . From an oncological perspective, CD44 has gained importance due to its pleiotropic functioning either as oncogene or tumor suppressor depending on the type of ligand involved, tumor specific mutations and regulation [167, 168] . Growth promotion by CD44 and its isoforms occurs by binding to growth factors leading to formation of a complex with ezrin, promoting signaling to the nucleus and cytoskeletal organization [167] . Tumor suppression occurs by binding of HA to CD44 and leading to formation of a complex with merlin, which prevents signaling to the nucleus and the cell cycle, and the formation of variant splicing isoforms [168] . CD44 is also essential for tumor metastasis to liver, lungs and bone marrow via its binding to HA; two major organs wherein tumor cell homing followed by metastasis occurs frequently include liver and bone marrow, which are rich in hyaluronic acid (HA) [169] . Studies have shown up-regulation of HA on stimulation with tumor necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) in endothelial cells [170] [171] [172] . Within the tumor microenvironment this leads to alternate splicing of CD44, thereby up-regulating CD44variant proteins. Various groups have demonstrated use of anti-CD44 antibodies to prevent or reduce metastasis [173, 174] . Soluble versions of CD44 have been shown to efficiently inhibit haematogenous dissemination of lymphoma [175] , melanoma [176] and breast cancer cells [177] .
CONCLUDING REMARKS AND FUTURE PERSPECTIVES
Rapidly proliferating cells are the primary targets of most current chemotherapeutic agents. Drugs like taxol basedpaclitaxel, docitaxel; platinum based -cisplatin, carboplatin; alkaloids -vincristine, vinblastin are the major primary line of action. The stemness attribute of CSCs has been successful in keeping a minimal residual disease which in time develops into tumor relapse [178, 179] . With extracellular matrix playing a critical role in development of tissue modelling, development and regeneration, it is apparent that these will have significant role in therapeutic designing. Required for both physical support and molecular signaling, ECM can act as physical base for cells to grow upon to acting as a barrier and contain the tissue/ organ morphology besides being a zone of nutrient/growth factor availability and trafficking. However, ECM is not a passive participant as is revealed from its aberrant modulation in several diseases including cancer. With continuous of information on SCs available and ECM driving their fate, it is apparent that parallels with CSCs cannot be overlooked. Pathways essential for development are identified to be dysregulated in tumors and may be critical in targeting CSCs. Extracellular matrix components regulate these key pathways including Wnt/b-catenin, hedgehog, Notch, PI3K/Akt [24, 180, 181] .
Demonstration of changes in cellular properties including phenotype, organization, differentiation and functionality on exposure to ECM in appropriate two dimensional vs. three dimensional culture models (2D vs. 3D cultures) have significantly impacted the understanding of role played by ECM in tissue and tumor niches [182] (Box 4). In vitro 3D culture based studies in oncology show an immense involvement of scaffolds in cellular behaviour. The advent of orthotopic models with cells cultured in 3D [183] and in bioreactors [184] has exemplified 3D potential in exercise. Differences in drug sensitivities between 2D and 3D based culture assays have indicated 3D systems to be more appropriate for predicting improved clinical outcome [185] [186] [187] .
The diversity and heterogeneity of the ECM components expressed make them excellent targets for therapy.
Box 4. 3D culturing -conditioned environment approximated for natural simulation
The topographically simple flat surface of in vitro culture has been in the forefront towards understanding biological mechanisms involved in cellular functions. An upsurge in the development of 3-dimensional matrix supports led to various forms scaffolds being sourced. These materials include reconstituted basement membrane like Matrigel (232), fibroblast derived stromal ECM (233) collagen (234) and fibrin gels. Awareness of batch to batch variations led to the development of synthetic gels for example, polyethylene glycol (PEG)-based hydrogels (235) , cryogels, self-assembling peptides (236) . These gels provide a standard composition of growth factors and porosity that facilitates a consistent identification of cellular responses upon experimentation.
Hence targeting ECM molecules like fibronectin receptor, very late activation protein (VLA4) [188] and hyaluronic acid receptor CD44 [189] among others is crucial and have shown positive responses since this effectively regulates developmentally significant pathways -Notch, Wnt and Hedgehog [190, 192] . However, the similarity between the SC and CSC niches makes the task arduous to achieve and will require carefully designed therapeutic regimes in clinical studies with defined, disease-free or recurrencefree survival as endpoints. The emergence of theranostics (portmanteau of 'therapeutics' and 'diagnostics'), has conjugated the application of molecular markers and involvement of disease diagnostics [193] . This, although not yet implicated in CSCs niche identification in clinical studies, has tremendous potential in developing newer methods and biotechnological inventions which will identify CSCs and their niche in patients. Such a technological advancement will be a turning of new leaf which will lead us directly to translation of the molecular research into diagnosis and therapeutics.
